Related Experiment Video
Updated: Apr 14, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Development and characterization of Haemophilus influenzae type b conjugate vaccine prepared using different
1MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd., 2nd Floor, Nanotechnology Building, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India.
Insights
Developing a cost-effective Haemophilus influenzae type b (Hib) conjugate vaccine is crucial. This study optimized Hib capsular polysaccharide (PRP)-tetanus toxoid (TT) conjugates, finding low molecular weight versions more immunogenic in rats.
Area of Science:
- Vaccinology
- Microbial immunology
- Bioconjugation chemistry
Background:
- Haemophilus influenzae type b (Hib) capsular polysaccharide conjugates are vital for childhood vaccines.
- High costs limit access to essential Hib conjugate vaccines for vulnerable populations.
Purpose of the Study:
- To develop a cost-effective and more immunogenic Hib conjugate vaccine.
- To optimize the preparation of Hib capsular polysaccharide (PRP)-tetanus toxoid (TT) conjugates.
Main Methods:
- Controlled periodate oxidation introduced aldehyde groups into Hib polysaccharide.
- Reductive amination covalently linked polysaccharide to hydrazide-derivatized tetanus toxoid.
- Polysaccharide chain length was reduced to 100, 50kDa, or 10kDa oligosaccharides.
Main Results:
- Hib PRP-TT conjugates were successfully prepared with polysaccharide-to-protein ratios of 0.25-0.5 (w/w).
- Conjugates exhibited low free saccharide levels (<10%).
- Immunization of rats elicited specific anti-PRP antibodies, with low molecular weight conjugates showing superior immunogenicity.
Conclusions:
- Optimized PRP-TT conjugates offer a promising strategy for more affordable and potent Hib vaccines.
- Low molecular weight Hib polysaccharide-tetanus toxoid conjugates demonstrate enhanced immunogenicity.
- This approach could improve global access to essential Hib vaccination.
Abstract:
Capsular polysaccharide conjugates of Haemophilus influenzae type b (Hib) are important components of several mono- or multi-valent childhood vaccines. However, their access to the most needy people is limited due to their high cost. As a step towards developing a cost effective and more immunogenic Hib conjugate vaccine, we present a method for the preparation of Hib capsular polysaccharide (PRP)-tetanus toxoid (TT) conjugates using optimized PRP chain length and conjugation conditions. Reactive aldehyde groups were introduced into the polysaccharides by controlled periodate oxidation of the native polysaccharide, which were subsequently covalently linked to hydrazide derivatized tetanus toxoid by means of reductive amination. Native polysaccharides were reduced to average 100 or 50kDa polysaccharide and 10kDa oligosaccharides in a controlled manner. Various conjugates were prepared using Hib polysaccharide and oligosaccharide yielding conjugates with polysaccharide to protein ratios in the range of 0.25-0.5 (w/w) and free saccharide levels of less than 10%. Immunization of Sprague Dawley rats with the conjugates elicited specific antibodies to PRP. The low molecular weight PRP-TT conjugates were found to be more immunogenic as compared to their high molecular weight counterparts and the PRP-TT reference vaccine.
More Related Videos
Related Concept Videos
Vaccine Production
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Formation of Lipopolysaccharides

